Home Biosimilar Antibodies Others Others antibody Vopratelimab (Anti-ICOS / CD278) For research use only.
Not for use in humans.

Vopratelimab (Anti-ICOS / CD278)

Synonyms: JTX 2011

Vopratelimab (Anti-ICOS / CD278) is a humanized immunoglobulin G1-kappa agonist monoclonal antibody that binds specifically to the Inducible CO-Stimulator of T cells (ICOS). Vopratelimab exhibits antitumor immune response. MW: 145.5 KD.

Vopratelimab (Anti-ICOS / CD278)

Purity & Quality Control

≥99

Biological Activity

Description Vopratelimab (Anti-ICOS / CD278) is a humanized immunoglobulin G1-kappa agonist monoclonal antibody that binds specifically to the Inducible CO-Stimulator of T cells (ICOS). Vopratelimab exhibits antitumor immune response. MW: 145.5 KD.

Product Details

CAS No.  2039148-04-2
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Vopratelimab (Anti-ICOS / CD278) | Vopratelimab (Anti-ICOS / CD278) supplier | purchase Vopratelimab (Anti-ICOS / CD278) | Vopratelimab (Anti-ICOS / CD278) cost | Vopratelimab (Anti-ICOS / CD278) manufacturer | order Vopratelimab (Anti-ICOS / CD278) | Vopratelimab (Anti-ICOS / CD278) distributor